Research Groups

Recent Publications - 12 most recent publications

1. Motomura K., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nakazato Y., Tanaka Y., Nonoguchi N., Pierscianek D., Kim Y.H., Mariani L., Vital A., Perry A., Ohgaki H. (2013) PDGFRA gain in low-grade diffuse gliomas Journal of neuropathology and experimental neurology; 72(1):61-66. PMID: 23242283

2. Nagaishi M., Paulus W., Brokinkel B., Vital A., Tanaka Y., Nakazato Y., Giangaspero F., Ohgaki H. (2012) Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma Brain pathology; 22(5):670-676. PMID: 22288519

3. Motomura K., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nakazato Y., Tanaka Y., Pierscianek D., Kim Y.H., Mariani L., Vital A., Ohgaki H. (2012) DMBT1 Homozygous Deletion in Diffuse Astrocytomas Is Associated With Unfavorable Clinical Outcome Journal of neuropathology and experimental neurology; 71(8):702-707. PMID: 22805772

4. Nagaishi M., Kim Y.H., Mittelbronn M., Giangaspero F., Paulus W., Brokinkel B., Vital A., Tanaka Y., Nakazato Y., Legras-Lachuer C., Lachuer J., Ohgaki H. (2012) Amplification of the STOML3, FREM2, and LHFP Genes Is Associated with Mesenchymal Differentiation in Gliosarcoma American journal of pathology; 180(5):1816-1823. PMID: 22538188

5. Lv S.Q., Kim Y.H., Giulio F., Shalaby T., Nobusawa S., Yang H., Zhou Z., Grotzer M., Ohgaki H. (2012) Genetic Alterations in MicroRNAs in Medulloblastomas Brain pathology; 22(2):230-239. PMID: 21793975

6. Nobusawa S., Stawski R., Kim Y.H., Nakazato Y., Ohgaki H. (2011) Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study Neuropathology; 31(6):583-588. PMID: 21382095

7. Grunder E., D'Ambrosio R., Fiaschetti G., Abela L., Arcaro A., Zuzak T., Ohgaki H., Lv S.Q., Shalaby T., Grotzer M. (2011) MicroRNA-21 suppression impedes medulloblastoma cell migration European journal of cancer; 47(16):2479-2490. PMID: 21775132

8. Kim Y.H., Lachuer J., Mittelbronn M., Paulus W., Brokinkel B., Keyvani K., Sure U., Wrede K., Nobusawa S., Nakazato Y., Tanaka Y., Vital A., Mariani L., Ohgaki H. (2011) Alterations in the RB1 Pathway in Low-grade Diffuse Gliomas Lacking Common Genetic Alterations Brain pathology; 21(6):645-651. PMID: 21470325

9. Kim Y.H., Pierscianek D., Mittelbronn M., Vital A., Mariani L., Hasselblatt M., Ohgaki H. (2011) TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations Journal of clinical pathology; 64(10):850-852. PMID: 21690245

10. Ohgaki H., Kleihues P. (2011) Genetic profile of astrocytic and oligodendroglial gliomas Brain Tumor Pathol; 28(3):177-183. PMID: 21442241

11. Chargari C., Comperat E., Magne N., Vedrine L., Houlgatte A., Egevad L., Camparo P. (2011) Prostate needle biopsy examination by means of virtual microscopy Pathol Res Pract; 207(6):366-369. PMID: 21570778

12. Fiaschetti G., Castelletti D., Zoller S., Schramm A., Schroeder C., Nagaishi M., Stearns D., Mittelbronn M., Eggert A., Westermann F., Ohgaki H., Shalaby T., Pruschy M., Arcaro A., Grotzer M.A. (2011) Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma Oncogene; 30(25):2823-2835. PMID: 21317922